Cocrystal Systems of Pharmaceutical Interest: 2011BRITTAIN, Harry G.Crystal growth & design. 2012, Vol 12, Num 11, pp 5823-5832, issn 1528-7483, 10 p.Article

Vibrational Spectroscopic Studies of Cocrystals and Salts. 3. Cocrystal Products Formed by Benzenecarboxylic Acids and Their Sodium SaltsBRITTAIN, Harry G.Crystal growth & design. 2010, Vol 10, Num 4, pp 1990-2003, issn 1528-7483, 14 p.Article

Polymorphism and Solvatomorphism 2006BRITTAIN, Harry G.Journal of pharmaceutical sciences. 2008, Vol 97, Num 9, pp 3611-3636, issn 0022-3549, 26 p.Article

Fluorescence studies of the dehydration of cefadroxil monohydrateBRITTAIN, Harry G.Journal of pharmaceutical sciences. 2007, Vol 96, Num 10, pp 2757-2764, issn 0022-3549, 8 p.Article

Polymorphism and solvatomorphism 2005BRITTAIN, Harry G.Journal of pharmaceutical sciences. 2007, Vol 96, Num 4, pp 705-728, issn 0022-3549, 24 p.Article

Particle-size distribution, Part III: Determination by analytical sievingBRITTAIN, Harry G.Pharmaceutical technology. 2002, Vol 26, Num 12, pp 56-64, issn 0147-8087, 5 p.Article

What is the correct method to use for particle-size determination?BRITTAIN, Harry G.Pharmaceutical technology. 2001, Vol 25, Num 7, pp 96-98, issn 0147-8087Article

Vibrational Spectroscopic Studies of Cocrystals and Salts. 1. The Benzamide―Benzoic Acid SystemBRITTAIN, Harry G.Crystal growth & design. 2009, Vol 9, Num 5, pp 2492-2499, issn 1528-7483, 8 p.Article

Vibrational Spectroscopic Studies of Cocrystals and Salts. 2. The Benzylamine—Benzoic Acid SystemBRITTAIN, Harry G.Crystal growth & design. 2009, Vol 9, Num 8, pp 3497-3503, issn 1528-7483, 7 p.Article

Particle-size distribution IV: Determination by laser-light scatteringBRITTAIN, Harry G.Pharmaceutical technology (2003). 2003, Vol 27, Num 10, pp 102-114, issn 1543-2521, 7 p.Article

Cocrystal Systems of Pharmaceutical Interest: 2010BRITTAIN, Harry G.Crystal growth & design. 2012, Vol 12, Num 2, pp 1046-1054, issn 1528-7483, 9 p.Article

Particle-size distribution II: The problem of sampling powdered solidsBRITTAIN, Harry G.Pharmaceutical technology. 2002, Vol 26, Num 7, pp 67-73, issn 0147-8087, 5 p.Article

Vibrational Spectroscopic Studies of Cocrystals and Salts. 4. Cocrystal Products formed by Benzylamine, α-Methylbenzylamine, and their Chloride SaltsBRITTAIN, Harry G.Crystal growth & design. 2011, Vol 11, Num 6, pp 2500-2509, issn 1528-7483, 10 p.Article

Polymorphism and Solvatomorphism 2008BRITTAIN, Harry G.Journal of pharmaceutical sciences. 2010, Vol 99, Num 9, pp 3648-3664, issn 0022-3549, 17 p.Article

Polymorphism and Solvatomorphism 2007BRITTAIN, Harry G.Journal of pharmaceutical sciences. 2009, Vol 98, Num 5, pp 1617-1642, issn 0022-3549, 26 p.Article

Fluorescence studies of the transformation of carbamazepine anhydrate Form III to its dihydrate phaseBRITTAIN, Harry G.Journal of pharmaceutical sciences. 2004, Vol 93, Num 2, pp 375-383, issn 0022-3549, 9 p.Article

Particle-size distribution. Part I. Representations of particle representations of partide shape, size, and distributionBRITTAIN, Harry G.Pharmaceutical technology. 2001, Vol 25, Num 12, pp 38-45, issn 0147-8087, 6 p.Article

X-ray diffraction II : Using single-crystal X-ray diffraction to study polymorphism and solvatomorphismBRITTAIN, Harry G.Pharmaceutical technology. 2000, Vol 24, Num 9, pp 116-125, issn 0147-8087, 6 p.Article

Crystalline solidsVIPPAGUNTA, Sudha R; BRITTAIN, Harry G; GRANT, David J. W et al.Advanced drug delivery reviews. 2001, Vol 48, Num 1, pp 3-26, issn 0169-409XArticle